• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

洞悉心肌肥厚:一项基于心脏磁共振研究乳头肌质量和 T1 映射的研究。

Insight into hypertrophied hearts: a cardiovascular magnetic resonance study of papillary muscle mass and T1 mapping.

机构信息

Barts Heart Centre, London, UK.

Sydney Medical School, University of Sydney, Sydney, Australia.

出版信息

Eur Heart J Cardiovasc Imaging. 2017 Sep 1;18(9):1034-1040. doi: 10.1093/ehjci/jew187.

DOI:10.1093/ehjci/jew187
PMID:27590835
Abstract

AIMS

Left ventricular papillary muscles (LVPM) can appear disproportionately hypertrophied, particularly in Fabry disease (FD) where storage appears detectable by cardiovascular magnetic resonance (CMR) T1 mapping. The aim of the study was to measure LVPM mass in heart diseases with left ventricular hypertrophy (LVH) and to gain insight into the mechanisms of LVPM hypertrophy in FD.

METHODS AND RESULTS

Four hundred and seventy-eight cases were retrospectively recruited: 125 FD, 85 hypertrophic cardiomyopathy (HCM), 67 amyloid, 82 aortic stenosis (AS), 40 hypertension, 79 controls. LVPM contribution to LVM was manually contoured on CMR short axis cines. T1 values (septal, LVPM) were measured using ShMOLLI sequences in FD and controls. LVPM contribution to LVM was highest in LVH+ve FD and significantly increased compared to all other LVH+ve groups (FD 13 ± 3%, HCM 10 ± 3%, amyloid 8 ± 2%, AS 7 ± 3%, hypertension 7 ± 2%, controls 7 ± 1%; P < 0.001). LVH+ve HCM also had significantly increased LVPM. In LVH-ve cohorts, only FD had significantly increased LVPM (11 ± 3%; P < 0.001). In FD there was concordant septal and LVPM T1. LVH+ve FD: when septal T1 was low, LVPM T1 was low in 90%. LVH-ve FD: when septal T1 was normal, LVPM T1 was normal in 70% (indicating no detectable storage); when septal T1 was low, 75% had low LVPM T1 (indicating storage). LVPM hypertrophy was similar between the low and normal septal T1 groups (11 ± 3% vs. 10 ± 3%, P = 0.08).

CONCLUSION

Disproportionate hypertrophy of LVPMs in LVH+ve hearts occurred in FD and HCM. This phenomenon also occurred in LVH-ve FD. Low T1 was not always present in FD LVPM hypertrophy, implying additional mechanisms activating hypertrophy signalling pathways.

摘要

目的

左心室乳头肌(LVPM)可能会出现不成比例的肥大,特别是在法布里病(FD)中,通过心血管磁共振(CMR)T1 映射可以检测到储存。本研究的目的是测量左心室肥厚(LVH)心脏病患者的 LVPM 质量,并深入了解 FD 中 LVPM 肥大的机制。

方法和结果

回顾性招募了 478 例病例:125 例 FD、85 例肥厚型心肌病(HCM)、67 例淀粉样变性、82 例主动脉瓣狭窄(AS)、40 例高血压、79 例对照。使用 CMR 短轴电影手动描绘 LVPM 对 LVM 的贡献。在 FD 和对照组中使用 ShMOLLI 序列测量 T1 值(间隔、LVPM)。LVPM 对 LVM 的贡献在 LVH+ve FD 中最高,与所有其他 LVH+ve 组相比显著增加(FD 13±3%、HCM 10±3%、淀粉样变性 8±2%、AS 7±3%、高血压 7±2%、对照组 7±1%;P<0.001)。LVH+ve HCM 也有显著增加的 LVPM。在 LVH-ve 队列中,只有 FD 有显著增加的 LVPM(11±3%;P<0.001)。在 FD 中,间隔和 LVPM 的 T1 是一致的。LVH+ve FD:当间隔 T1 较低时,90%的 LVPM T1 也较低。LVH-ve FD:当间隔 T1 正常时,70%的 LVPM T1 正常(表明无明显储存);当间隔 T1 较低时,75%的 LVPM T1 较低(表明储存)。低和正常间隔 T1 组之间的 LVPM 肥大相似(11±3%比 10±3%,P=0.08)。

结论

LVH+ve 心脏中 LVPM 的不成比例肥大发生在 FD 和 HCM 中。这种现象也发生在 LVH-ve FD 中。FD 的 LVPM 肥大并不总是存在低 T1,这意味着存在激活肥大信号通路的其他机制。

相似文献

1
Insight into hypertrophied hearts: a cardiovascular magnetic resonance study of papillary muscle mass and T1 mapping.洞悉心肌肥厚:一项基于心脏磁共振研究乳头肌质量和 T1 映射的研究。
Eur Heart J Cardiovasc Imaging. 2017 Sep 1;18(9):1034-1040. doi: 10.1093/ehjci/jew187.
2
Loss of base-to-apex circumferential strain gradient assessed by cardiovascular magnetic resonance in Fabry disease: relationship to T1 mapping, late gadolinium enhancement and hypertrophy.通过心血管磁共振评估法布里病的基底-顶点周向应变梯度缺失:与 T1 映射、晚期钆增强和心肌肥厚的关系。
J Cardiovasc Magn Reson. 2019 Aug 1;21(1):45. doi: 10.1186/s12968-019-0557-0.
3
The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage.法布瑞氏病心肌表型的肥大前期和可检测存储前期。
Eur Heart J Cardiovasc Imaging. 2021 Jun 22;22(7):790-799. doi: 10.1093/ehjci/jeaa101.
4
Screening for Fabry disease in patients with hypertrophic cardiomyopathy using cardiac magnetic resonance imaging.使用心脏磁共振成像对肥厚型心肌病患者进行法布里病筛查。
Eur Radiol. 2025 May;35(5):2888-2898. doi: 10.1007/s00330-024-11203-7. Epub 2024 Nov 19.
5
Differentiation between Fabry disease and hypertrophic cardiomyopathy with cardiac T1 mapping.应用心脏 T1 mapping 技术对法布里病与肥厚型心肌病进行鉴别诊断。
Diagn Interv Imaging. 2020 Feb;101(2):59-67. doi: 10.1016/j.diii.2019.08.006. Epub 2019 Sep 10.
6
A disproportionate contribution of papillary muscles and trabeculations to total left ventricular mass makes choice of cardiovascular magnetic resonance analysis technique critical in Fabry disease.乳头肌和小梁在左心室总质量中所占比例过高,这使得心血管磁共振分析技术的选择在法布里病中至关重要。
J Cardiovasc Magn Reson. 2015 Feb 21;17(1):22. doi: 10.1186/s12968-015-0114-4.
7
Global longitudinal strain, myocardial storage and hypertrophy in Fabry disease.法布瑞氏病患者的心肌纵向应变、心肌贮备和心肌肥厚。
Heart. 2019 Mar;105(6):470-476. doi: 10.1136/heartjnl-2018-313699. Epub 2018 Oct 3.
8
Proposed Stages of Myocardial Phenotype Development in Fabry Disease.法布里病心肌表型发育的拟议阶段。
JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 2):1673-1683. doi: 10.1016/j.jcmg.2018.03.020. Epub 2018 May 16.
9
Characterization of Fabry Disease cardiac involvement according to longitudinal strain, cardiometabolic exercise test, and T1 mapping.根据纵向应变、心脏代谢运动试验和 T1 映射对法布里病心脏受累进行特征描述。
Int J Cardiovasc Imaging. 2020 Jul;36(7):1333-1342. doi: 10.1007/s10554-020-01823-7. Epub 2020 May 8.
10
Early segmental relaxation abnormalities in hypertrophic cardiomyopathy for differential diagnostic of patients with left ventricular hypertrophy.肥厚型心肌病早期节段性舒张异常对左心室肥厚患者的鉴别诊断价值
Clin Cardiol. 2017 Nov;40(11):1026-1032. doi: 10.1002/clc.22761. Epub 2017 Jul 24.

引用本文的文献

1
Echocardiography in Cardiac Amyloidosis: From Identification to Classification.心脏淀粉样变的超声心动图:从识别到分类
JACC Asia. 2025 May;5(5):647-649. doi: 10.1016/j.jacasi.2025.03.002. Epub 2025 Apr 22.
2
Echocardiographic Features of Wild-Type Transthyretin Cardiac Amyloidosis From J-Case: Multicenter Survey in Japan.来自J病例的野生型转甲状腺素蛋白心脏淀粉样变的超声心动图特征:日本多中心调查
JACC Asia. 2025 May;5(5):633-646. doi: 10.1016/j.jacasi.2025.01.016. Epub 2025 Mar 30.
3
Cardiovascular Computed Tomography and Magnetic Resonance Imaging Guideline of the Brazilian Society of Cardiology and the Brazilian College of Radiology - 2024.
巴西心脏病学会和巴西放射学会心血管计算机断层扫描与磁共振成像指南 - 2024年
Arq Bras Cardiol. 2024 Oct 28;121(9):e20240608. doi: 10.36660/abc.20240608.
4
Cardiovascular magnetic resonance insights into anomalies of the mitral valve apparatus in Fabry cardiomyopathy and hypertrophic cardiomyopathy.心血管磁共振对法布里心肌病和肥厚型心肌病二尖瓣装置异常的见解。
Front Cardiovasc Med. 2024 Sep 30;11:1458705. doi: 10.3389/fcvm.2024.1458705. eCollection 2024.
5
2024 Update of the TSOC Expert Consensus of Fabry Disease.《法布里病TSOC专家共识2024年更新》
Acta Cardiol Sin. 2024 Sep;40(5):544-568. doi: 10.6515/ACS.202409_40(5).20240731A.
6
Left Ventricular Papillary Muscle: Anatomy, Pathophysiology, and Multimodal Evaluation.左心室乳头肌:解剖学、病理生理学及多模态评估
Diagnostics (Basel). 2024 Jun 16;14(12):1270. doi: 10.3390/diagnostics14121270.
7
Fabry Disease: More than a Phenocopy of Hypertrophic Cardiomyopathy.法布里病:不仅仅是肥厚型心肌病的拟表型
J Clin Med. 2023 Nov 13;12(22):7061. doi: 10.3390/jcm12227061.
8
Prevalence of papillary muscle hypertrophy in fabry disease.法布里病患者心肌肌球蛋白肥厚的患病率。
BMC Cardiovasc Disord. 2023 Aug 27;23(1):424. doi: 10.1186/s12872-023-03463-w.
9
Papillary-Muscle-Derived Radiomic Features for Hypertrophic Cardiomyopathy versus Hypertensive Heart Disease Classification.用于肥厚型心肌病与高血压性心脏病分类的乳头肌衍生放射组学特征
Diagnostics (Basel). 2023 Apr 25;13(9):1544. doi: 10.3390/diagnostics13091544.
10
Multiparametric MRI identifies subtle adaptations for demarcation of disease transition in murine aortic valve stenosis.多参数 MRI 可识别出细微的适应性改变,有助于界定小鼠主动脉瓣狭窄疾病的转变。
Basic Res Cardiol. 2022 May 29;117(1):29. doi: 10.1007/s00395-022-00936-5.